Sanofi

U.S. FDA Licenses Sanofi Pasteur's New Influenza Vaccine Manufacturing Facility

- Sanofi Pasteur committed to increasing its seasonal and pandemic influenza preparedness; New facility will increase production capacity in the U.S. - SWIFTWATER, Pa. and LYON, France, May 6 /PRNewswire-FirstCall/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: SA...

US FDA licenses Sanofi Pasteur's new pediatric combination vaccine, pentacel

Swiftwater, PA - Lyon, France - June 23, 2008 - Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has licensed Pentacel®, Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus an...

U.S. FDA Licenses Sanofi Pasteur's New Pediatric Combination Vaccine, Pentacel(R)

- Pentacel(R) vaccine is the first 5-in-1 pediatric combination for immunization against diphtheria, tetanus, pertussis, polio and Haemophilus influenzae type b (Hib) - SWIFTWATER, Pa. and LYON, France, June 23 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of t...

Acambis Joins Forces With Sanofi Pasteur to Develop West Nile Virus Vaccine

CAMBRIDGE, England and CAMBRIDGE, Massachusetts, November 13 /PRNewswire-FirstCall/ -- - No Human Vaccine Currently Exists Against the West Nile Virus, Which has Caused 3,265 Cases and 92 Deaths in the US so far in 2007; Collaboration Aims to Bring Leading West Nile Virus Vaccine Candidate to...

Sanofi-Aventis Recognized for Workplace Efforts to Prevent Cancer

...ion CEO Roundtable on Cancer, in recognition of the company's extensive efforts to encourage employees at all U.S. facilities (sanofi-aventis U.S. and sanofi pasteur) to take an active role in their health and reduce their risks of developing cancer. The CEO Cancer Gold Standard is awarded to companies t...

Perrigo Announces FDA Approval for Generic Version of NASACORT(R) AQ

...11. Perrigo will share in the costs and benefits in Teva's marketing of the products under the agreement. The product is the AB-rated equivalent to sanofi - Aventis' Nasacort(R) AQ, indicated for the treatment of the nasal symptoms of seasonal and year round allergies in adults and children six years of ...

Sanofi Pasteur Begins Shipments of Fluzone(R), Influenza Virus Vaccine for 2009-2010 Seasonal Influenza

... SWIFTWATER, Pa., July 27 /PRNewswire/ -- sanofi Pasteur, the vaccines division of sanofi-aventis G... young as 6 months of age through adults. sanofi Pasteur, the only U.S. manufacturer of inactivated...seasonal influenza immunization efforts. In total, sanofi Pasteur expects to supply over 50 million doses of...

U.S. Expects 160 Million Doses of Swine Flu Vaccine by October

...so look at whether one or two doses of 30 micrograms are more effective. The two-dose regimens will be given three weeks apart. Two manufacturers, sanofi Pasteur and CSL Biotherapies, produced the vaccines. If these trials seem safe, the vaccines will also be tested in children aged 6 months to 17 ye...

U.S. Swine Flu Vaccine Trials Set to Begin

...so look at whether one or two doses of 30 micrograms are more effective. The two-dose regimens will be given three weeks apart. Two manufacturers, sanofi Pasteur and CSL Biotherapies, produced the vaccines. If these trials seem safe, the vaccines will also be tested in children aged 6 months to 17 ye...

Young Adults Unaware of Threat of Infectious Disease and the Availability of Preventive Vaccines

...d by the National Foundation for Infectious Diseases and supported by unrestricted educational grants from GlaxoSmithKline, Merck & Co., Inc., sanofi pasteur and Wyeth Pharmaceuticals. ...

Sanofi in Medical Technology

Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA

...ance and SWIFTWATER, Pa., Aug. 7 /PRNewswire/ -- sanofi Pasteur, the vaccines division of the sanofi-avent...e Pisano, President and Chief Executive Officer of sanofi Pasteur. "It is essential that we pursue the vacc...ntained in the annual seasonal influenza vaccines. sanofi Pasteur's influenza A(H1N1) 2009 monovalent vaccin...

Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS

...nologies, Intercell has strategic partnerships with a number of global pharmaceutical companies, including Novartis, Merck & Co., Inc., Wyeth, and sanofi Pasteur. The Company's pipeline includes a Travelers' Diarrhea Vaccine Patch (Phase II concluded), a Pseudomonas vaccine candidate (Phase II), a ...

Progress Against Malaria and Other Infectious Diseases Among Highlights at Annual Vaccine Conference

...ped from his father's laboratory eventually became sanofi pasteur, the world's largest vaccine maker. The Me...rwritten by an unrestricted educational grant from sanofi pasteur. Other Top Scientists to Lecture ... to Avian Influenza Vaccine Researchers from sanofi pasteur will present findings that indicate the co...

Intercell Starts a Phase I Clinical Trial for a New Streptococcus pneumoniae Vaccine

...nologies, Intercell has strategic partnerships with a number of global pharmaceutical companies, including Novartis, Merck & Co., Inc., Wyeth, and sanofi Pasteur. The Company's pipeline includes a Travelers' Diarrhea Vaccine Patch (Phase II), a Pseudomonas vaccine candidate (Phase II), a Vaccine En...

Sanofi Pasteur Dengue Vaccine Enters Pediatric Efficacy Clinical Study

...e Endemic Regions in Latin America and Asia sanofi Pasteur, the vaccines division of sanofi-aventis G...he most widespread tropical disease after malaria. sanofi Pasteur's tetravalent dengue vaccine candidate is ...o reach this stage of clinical development. sanofi Pasteur is collaborating with Mahidol University o...

Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile

...YON, France, February 17 /PRNewswire-FirstCall/ -- sanofi Pasteur, the vaccines division of sanofi-aventis G...ingdom is investigating the safety and efficacy of sanofi pasteur's C. difficile candidate vaccine. While th...ncy and the lead investigator of the trial. sanofi Pasteur's candidate vaccine uses a toxoid-based ap...

Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated

... www.lungusa.org . The American Lung Association's Faces of Influenza educational initiative is made possible through a collaboration with sanofi pasteur. Press Contact: Heather Grzelka American Lung Association hgrzelka@lungusa.org 202-715-3450 Brooke Sal...

Daiichi Sankyo and Lilly Respond to Speculation on Status of Prasugrel New Drug Application

...vides answers - through medicines and information - for some of the world's most urgent medical needs. P-LLY Plavix is a registered trademark of sanofi Aventis Corp. This press release contains certain forward-looking statements about the potential of the investigational compound prasugrel (CS-747, L...

Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients

... PARIS, and TORONTO, Sept. 17 /PRNewswire/ -- sanofi pasteur, the vaccines division of the sanofi-avent...s (EURONEXT: SAN) and in New York (NYSE: SNY ). sanofi pasteur, the vaccines division of sanofi-aventis G...the globe. A world leader in the vaccine industry, sanofi pasteur offers the broadest range of vaccines prot...

Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program

...ese technologies, Intercell has strategic partnerships with a number of global pharmaceutical companies, including Novartis, Merck & Co., Inc., Wyeth, sanofi Pasteur, Kirin and the Statens Serum Institut. The Company's lead product is a vaccine against Japanese Encephalitis. That vaccine successfully conc...

Sanofi in Medical Dictionary

Deep vein thrombosis

...n thrombosis (DVT) is a common but serious medical condition that occurs ... The Coalition to Prevent Deep - Vein Thrombosis (DVT) is funded by sanofi ... ...

Sanofi in Biological News

Swine flu experts gather at New York Academy of Sciences May 28

...dicine and Dentistry; Philip R. Dormitzer, Novartis Vaccines; Scott Harper, New York City Department of Health and Mental Hygiene; and James Matthews, sanofi Pasteur, moderator. ...

Genomics-based vaccine could prevent deadly cattle disease

... research team included scientists from: the Ludwig Institute for Cancer Research in Brussels; the Wellcome Trust Center for Human Genetics in Oxford; sanofi Pasteur in Toronto; the University of Edinburgh; and Merial SAS, an international animal health company. ILRI and Merial have partnered to develop a v...

H5N1 avian flu virus vaccine induces immune responses in healthy adults

... any clinically significant abnormalities The vaccine, made from an inactivated H5N1 virus isolated in Southeast Asia in 2004, was manufactured by sanofi pasteur, Swiftwater, PA, under contract to NIAID. Because there are no manufacturers licensed in the United States to use adjuvants in inactivated inf...

Volunteers sought for avian flu vaccine study

...lity rate - approximately 72 percent - with many fatalities among previously healthy young people. The vaccine researchers are testing was made by sanofi Pasteur from an inactivated H5N1 avian flu virus isolated last year. "It's similar to the concept of the regular flu vaccine that people get every ...

'EuroVacc 02' HIV Vaccine Trial Begins

... - were developed within the network European Vaccine Effort against HIV/AIDS. NYVAC-HIV-C (a vaccine candidate based on poxvirus) was manufactured by sanofi pasteur - the vaccine division of Sanofi-Aventis - and has already been evaluated in a phase I study (EuroVacc 01) at the same clinical centres in Lau...

NIAID Initiates Trial of Experimental Avian Flu Vaccine

...spond to an avian flu pandemic,?adds Dr. Fauci. sanofi pasteur, Swiftwater, PA, manufactured the trial va... an H5N1 virus isolated in Southeast Asia in 2004. sanofi pasteur, formerly Aventis Pasteur, was awarded a c... In addition to the previous contract awarded to sanofi pasteur, in May 2004 NIAID also awarded a contract...

Sanofi in Biological Technology

Russia Chooses Inactivated Polio Vaccine from Sanofi Pasteur for Primary Immunization of all Infants

Sanofi Pasteur and Chumakov Institute Russian Academy Medical Sciences Providers of Inactivated Polio Vaccine (IPV) IMOVAX PolioTM for Russia National "Project Health" PARIS, November 12 /PRNewswire-FirstCall/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis...

U.S. Government Accepts $192 Million of sanofi pasteur H5N1 Bulk Vaccine Antigen for Pandemic Stockpile

- Vaccine for new strain of virus broadens government readiness program - SWIFTWATER, Pa. and LYON, France, April 28 /PRNewswire-FirstCall/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that the U.S. Department of Health and Human Services (HHS) has accepted ...

Maxygen Licenses Dengue Vaccine Technology to sanofi pasteur

REDWOOD CITY, Calif., Dec. 4 /PRNewswire-FirstCall/ -- Maxygen, Inc. (Nasdaq: MAXY ), a biotechnology company focused on the development of improved protein drugs, announced today the license of its proprietary dengue virus antigen technology to sanofi pasteur, the vaccines division of the sa...

"Over the Next 2-3 Years We Will Leverage Developmental Capabilities and Explore In-licensing and a Co-development Model to Consolidate Our Presence in Japan" - Dr. Kailash Sharma, President, Japan Operations, Zydus Cadila

...ool, Japan and an Executive MBA from Temple University , Philadelphia, USA, Dr. Sharma has earlier worked with Eisai, Nippon Boehringer Ingelheim and sanofi - Aventis, Japan and has successfully managed the core functions in all phases of drug development cycles. Last but not least, being in Japan for abou...

Sanofi-aventis Announces Second Quarter 2009 Results

...U.S. Food and Drug Administration licensed the new sanofi pasteur influenza vaccine manufacturing facility i...valent seasonal influenza vaccine per year. sanofi Pasteur received several orders to produce a vacci... as well as a contract from the French government. sanofi Pasteur is in discussion with several other govern...

Looking Older Than You Are May Have Little to Do With Wrinkles

...purposes for 10 years. Both experts are often linked in research, training and video training modules for Dermik. Dermik is the dermatology arm of sanofi Aventis, one of Europe's largest pharmaceutical companies. Full cosmetic application approval from the FDA is expected in the U.S within months. ...

Sanofi Pasteur Responds to Nation's Need for Hib Vaccine With Increased Supply

...e - SWIFTWATER, Pa., June 25 /PRNewswire/ -- sanofi Pasteur, the vaccines division of the sanofi-avent... of Hib vaccine from the market. Since that time, sanofi Pasteur has been, and continues to be, the sole supplier of Hib vaccine to the U.S. market. sanofi Pasteur is able to meet the nation's need for Hib ...

Hospira Receives Favorable Court Decision on Eloxatin(R)

...nounced that the U.S. District Court for the District of New Jersey has granted summary judgment of non-infringement in Hospira's favor with regard to sanofi Aventis' chemotherapy medication Eloxatin(R), and that Hospira has tentative approval from the U.S. Food and Drug Administration (FDA) for its generic...

Sanofi Pasteur Receives Seed Virus to Produce New Influenza A(H1N1) Vaccine

...and LYON, France, May 27 /PRNewswire-FirstCall/ -- sanofi Pasteur, the vaccines division of the sanofi-avent...As a company committed to protecting human health, sanofi Pasteur looks forward to quickly understanding how...duction," said Wayne Pisano, President and CEO of sanofi Pasteur. "This is an important step for engaging...

Intercell Announces European Approval of New Vaccine, IXIARO(R), to Prevent Japanese Encephalitis

...technologies, Intercell has strategic partnerships with a number of global pharmaceutical companies, including Novartis, Merck & Co., Inc., Wyeth, sanofi Pasteur, Kyowa Hakko Kirin and the Statens Serum Institut. The Company's development pipeline includes Phase II vaccine programs for Pseudomonas ...